These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polycystic ovary syndrome and the metabolic syndrome. Weerakiet S J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522 [TBL] [Abstract][Full Text] [Related]
5. Obesity and the polycystic ovary syndrome. Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153 [TBL] [Abstract][Full Text] [Related]
6. [The pathomechanism of polycystic ovary syndrome in the light of recent research findings]. Károlyi Z Orv Hetil; 2012 Oct; 153(40):1567-9. PubMed ID: 23022879 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and types of dyslipidemia in PCOS. Diamanti-Kandarakis E; Papavassiliou AG; Kandarakis SA; Chrousos GP Trends Endocrinol Metab; 2007 Sep; 18(7):280-5. PubMed ID: 17692530 [TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome in women. Schneider JG; Tompkins C; Blumenthal RS; Mora S Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375 [TBL] [Abstract][Full Text] [Related]
10. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance. Bethea SW; Nestler JE Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in young people. Poyrazoglu S; Bas F; Darendeliler F Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in women with polycystic ovary syndrome. Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960 [TBL] [Abstract][Full Text] [Related]
13. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome. Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702 [TBL] [Abstract][Full Text] [Related]
14. Predictors of insulin resistance in the obese with metabolic syndrome. Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595 [TBL] [Abstract][Full Text] [Related]
15. [Insulin resistance and infertility]. Koivunen R; Morin-Papunen L Duodecim; 2002; 118(5):509-15. PubMed ID: 12232991 [No Abstract] [Full Text] [Related]
16. Abdominal obesity and metabolic syndrome. Després JP; Lemieux I Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477 [TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in women with polycystic ovary syndrome. Essah PA; Nestler JE Fertil Steril; 2006 Jul; 86 Suppl 1():S18-9. PubMed ID: 16798277 [TBL] [Abstract][Full Text] [Related]
18. Role of obesity and adiposity in polycystic ovary syndrome. Diamanti-Kandarakis E Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437 [TBL] [Abstract][Full Text] [Related]
19. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study. Romualdi D; Costantini B; Campagna G; Lanzone A; Guido M Fertil Steril; 2008 Nov; 90(5):1826-33. PubMed ID: 18166189 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: is it a syndrome? Does it matter? Kahn R Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171 [No Abstract] [Full Text] [Related] [Next] [New Search]